SeD BioMedical (Certain Biotechnology Assets)

SeD BioMedical (Certain Biotechnology Assets) Overview

Status Acquired/​Merged
Latest Deal Type Asset Purch.
Financing Rounds 1

SeD BioMedical (Certain Biotechnology Assets) General Information

Description

A portfolio of four biotechnology platforms based in Singapore. The asset covers Flavonoid Compound Composition for treating neurological disorders such as Alzheimer's disease (Medical Food), Clorinated Myrectin Shuts down kinases linked to cancer, Praesidium Natural mosquito repellent and Path-way Anti-Pathogenic Solution Broad spectrum antimicrobial compound.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Primary Office
  • Singapore
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SeD BioMedical (Certain Biotechnology Assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SeD BioMedical (Certain Biotechnology Assets)‘s full profile, request access.

Request a free trial

SeD BioMedical (Certain Biotechnology Assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SeD BioMedical (Certain Biotechnology Assets)‘s full profile, request access.

Request a free trial